TauP301S mice immunized before onset also recovered from muscular atrophy and performed better than control mice in the hind-limb clasping and kyphosis assessments (Supplementary Fig.S4il). Then we compared NFT deposition in the hippocampus between PP-pTau31-vaccinated and control mice. not stated. Second, the most effective treatment time is not determined. Finally, the mechanism of action of pTau antibody is not fully elucidated. Here we developed a potent Noroviruses (NoVs) P particle (PP)-based active immunotherapy targeting optimal pathological tau species, exploited its effectiveness in premorbid and onset TauP301S mice and potential mechanisms of action in vivo. To elicit antibodies that recognize multiple phosphorylation sites while avoiding tau-specific T-cell activation, we designed three synthetic pTau peptides with a combination of up to four AD-related epitopes. pTau30 is usually phosphorylated at residues Ser202/Thr205/Ser238/Ser262; pTau31 is usually phosphorylated at residues Ser202/Thr205/Ser396/Ser404; pTau35 is usually phosphorylated at Ser238/Ser262/Ser396/Ser404 (Fig.1a, Supplementary ZM-447439 TableS1). Immunization assessments in C57BL/6 mice (Supplementary Fig.S1a) reflected that only pTau31-induced antibodies could recognize all carried four epitopes (Figs.1bd,S1bf). Furthermore, pTau31 could neither elicit non-phosphorylated Tau31-specific antibodies, nor stimulate tau-specific T-cell activation (Supplementary Fig.S1g, h). == Fig. 1. == aSchematic representation of the three candidate pTau peptides.bdConcentrations of pTauS205/T205-, pTauS396-, and pTauS404-specific antibodies induced by the candidate peptide after four doses of immunization. The concentration was calibrated to the AT8 antibody, PHF13 antibody, and pTauS404 polyclonal antibody in (b), (c), and (d), respectively.eSchematic representation of the PP-3C-pTau31 vaccine. All three mutant cysteines around the ZM-447439 loop of the PP-3C protein (red lines) have an opportunity to bind with the pTau31 peptide (blue lines) during air oxidation in (NH4)2CO3buffer.f,jChanges in the concentrations of pTau31-specific serum antibody in TauP301S mice from the premorbid and onset groups.g,kLevels of T-cell immunoreaction of isolated spleen cells from PP-3C and PP-pTau31 group when stimulated with different stimuli assessed by ELISpot assay in the premorbid and onset groups. All data represent the mean SEM.h,lRatio of gained weight in TauP301S mice from the premorbid and onset groups during the observation. Weight data of age- and sex-matched wild-type (WT) littermates during the same period are presented as a reference for normal mice.i,mSurvival of TauP301S mice in the premorbid and onset groups during the observation. nRepresentative figures of nest-building behavior for each group.o,pNest building test scores of TauP301S mice in the premorbid and onset groups.qIHC staining of pTauS202/T205 in the hippocampus of TauP301S mice brain after administration of vaccines.r,sQuantification of pTauS202/T205 signal stained by AT8 antibody in the hippocampus of TauP301S mice in the premorbid and onset cohorts. The results are expressed as IOD/area. In the premorbid cohort, the PP-pTau31 group showed 93.81% and 91.31% decreases compared to the PBS (p= 0.0029) and PP-3C group (p= 0.0202), respectively. In the onset cohort, the PP-pTau31 group showed 69.88% and 40.24% decreases compared to the PBS (p= 0.0007) and PP-3C groups, respectively.t,uLevels of human Tau (stained with HT7 antibody), pTauS202/T205 (stained ZM-447439 with AT8 antibody), pTauS396 (stained with PHF13 antibody), and pTauS404 in the brain homogenates of mice from the premorbid and onset cohorts after vaccination assessed by western blot assay. GAPDH served as the inner control. The Tau was indicated from the orange arrowheads or pTau music group. The blue arrowheads indicated the GAPDH music group. The relative content material of each test was designated under ladders.vConcentration of the full total human Tau proteins in the serum of TauP301S mice in the premorbid cohort through the observation. The dark arrowheads indicated the proper time points of immunization.wLevel from the pTau proteins containing the phosphorylation on Ser396 in the serum of TauP301S mice in the premorbid cohort through the observation. The dark arrowheads indicate the proper time points of immunization.xEffectiveness of mind homogenate-induced FRET of K280-CFP (KC) and K280-YFP (KY) co-transfected 293T cells from the premorbid cohort. KC + KY represent the baseline, and mind homogenate test of PBS, PP-3-C, or PP-pTau group was put into the cell moderate to check the propagation inhibition activity.yCortex of 9-month-old man TauP301S mice after staining with purified polyclonal antibodies through the immunosera of COCA1 most mice in the premorbid cohort. Antibodies had been diluted 50 folds for recognition. Scale pub: 50 m.zThe inhibition efficiency of serum antibodies from all mice in the premorbid cohort in inhibiting the toxicity of Tau protein ZM-447439 in TauP301S mice homogenate. 293T cells co-transfected with ZM-447439 K280-CFP (KC) and K280-YFP (KY) gene offered like a biosensor. The.